TORONTO DOMINION BANK - TEVA PHARMACEUTICAL FIN LLC ownership

TEVA PHARMACEUTICAL FIN LLC's ticker is and the CUSIP is 88163VAE9. A total of 49 filers reported holding TEVA PHARMACEUTICAL FIN LLC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
TORONTO DOMINION BANK ownership history of TEVA PHARMACEUTICAL FIN LLC
ValueSharesWeighting
Q4 2020$3,513,000
-44.9%
3,545,000
-45.8%
0.01%
-62.5%
Q3 2020$6,376,000
-73.0%
6,545,000
+8.3%
0.02%
-73.3%
Q2 2020$23,625,000
+290.6%
6,045,000
-7.0%
0.06%
+233.3%
Q1 2020$6,048,000
-2.2%
6,500,0000.0%0.02%
+80.0%
Q4 2019$6,181,0006,500,0000.01%
Other shareholders
TEVA PHARMACEUTICAL FIN LLC shareholders Q3 2020
NameSharesValueWeighting ↓
Radcliffe Capital Management, L.P. 70,783,000$69,363,0006.27%
INCOME RESEARCH & MANAGEMENT 14,978,000$14,536,0005.17%
PIPER SANDLER & CO. 5,000,000$4,852,0003.63%
Western Asset Management Company, LLC 42,946,000$42,102,0003.46%
PenderFund Capital Management Ltd. 4,000,000$5,225,0001.45%
Bracebridge Capital, LLC 5,500,000$5,335,0000.85%
WESTWOOD HOLDINGS GROUP INC 43,185,000$42,490,0000.54%
CORBYN INVESTMENT MANAGEMENT INC/MD 1,025,000$995,0000.52%
LMR Partners LLP 22,235,000$21,742,0000.45%
JUPITER ASSET MANAGEMENT LTD 35,000,000$34,357,0000.36%
View complete list of TEVA PHARMACEUTICAL FIN LLC shareholders